The first clinical site is open for the global SERENATA trial testing inhaled seralutinib for pulmonary hypertension linked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback